Literature DB >> 33109540

WNT Signaling Driven by R-spondin 1 and LGR6 in High-grade Serous Ovarian Cancer.

Sanghoon Lee1, John Jun2, William J Kim2, Pablo Tamayo2, Stephen B Howell3.   

Abstract

BACKGROUND/AIM: R-spondins control WNT signaling and RSPO1 and LGR6, two of its receptors, are uniquely expressed at high levels in high-grade serous ovarian cancer (HGSOC). The aim of this study was to assess the interrelations between the expression of the RSPOs and LGRs in HGSOC and in the ovarian surface (OSE) and fallopian tube surface epithelium (FTSE) from which HGSOC arises.
MATERIALS AND METHODS: Analysis of TCGA (HGSOC), CCLE (ovary), and other publicly accessed RNA-Seq data using UC San Diego Computational Cancer Analysis Library (CCAL) to perform differential expression analysis, association studies, and gene set inspection using the single-sample GSEA method. Additionally, we employed multiple publicly available databases including StringDB, Human Protein Atlas, and cBioPortal to aid the investigation.
RESULTS: Among normal tissues, expression of RSPO1, LGR5 and LGR6 was highest in the fallopian tube. The relative levels of expression of the RSPOs and LGRs in the OSE and FTSE matched those in HGSOC. RSPO1 and LGR6 were highly co-expressed in all three tissues. Gene set enrichment analysis (GSEA) showed that expression of RSPO1 was strongly linked to the enrichment of three separate WNT-driven GO pathways. Analysis of genes that impacted overall survival identified two other immediately adjacent genes that control WNT signaling, KREMEN1 and ZNRF3 whose expression and copy number were coordinately linked.
CONCLUSION: RSPO1 and LGR6 are coordinately expressed in HGSOC and the two normal tissues from which this tumor arises, and their expression is linked to WNT signaling pathways known the control cell fate and proliferation. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  R-spondin 1; ovarian cancer; spondins; wnt signaling

Mesh:

Substances:

Year:  2020        PMID: 33109540      PMCID: PMC9312105          DOI: 10.21873/anticanres.14623

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.435


  37 in total

1.  STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cells.

Authors:  Jong Wook Kim; Christian Berrios; Miju Kim; Amy E Schade; Guillaume Adelmant; Huwate Yeerna; Emily Damato; Amanda Balboni Iniguez; Laurence Florens; Michael P Washburn; Kim Stegmaier; Nathanael S Gray; Pablo Tamayo; Ole Gjoerup; Jarrod A Marto; James DeCaprio; William C Hahn
Journal:  Elife       Date:  2020-01-08       Impact factor: 8.140

2.  The Cancer Genome Atlas Pan-Cancer analysis project.

Authors:  John N Weinstein; Eric A Collisson; Gordon B Mills; Kenna R Mills Shaw; Brad A Ozenberger; Kyle Ellrott; Ilya Shmulevich; Chris Sander; Joshua M Stuart
Journal:  Nat Genet       Date:  2013-10       Impact factor: 38.330

3.  Inhibition of Wnt/β-catenin pathway by niclosamide: a therapeutic target for ovarian cancer.

Authors:  Rebecca C Arend; Angelina I Londoño-Joshi; Rajeev S Samant; Yonghe Li; Michael Conner; Bertha Hidalgo; Ronald D Alvarez; Charles N Landen; J Michael Straughn; Donald J Buchsbaum
Journal:  Gynecol Oncol       Date:  2014-04-13       Impact factor: 5.482

4.  Context-dependent activation or inhibition of Wnt-beta-catenin signaling by Kremen.

Authors:  Christopher S Cselenyi; Ethan Lee
Journal:  Sci Signal       Date:  2008-02-26       Impact factor: 8.192

5.  A Study of High-Grade Serous Ovarian Cancer Origins Implicates the SOX18 Transcription Factor in Tumor Development.

Authors:  Kate Lawrenson; Marcos A S Fonseca; Annie Y Liu; Felipe Segato Dezem; Janet M Lee; Xianzhi Lin; Rosario I Corona; Forough Abbasi; Kevin C Vavra; Huy Q Dinh; Navjot Kaur Gill; Ji-Heui Seo; Simon Coetzee; Yvonne G Lin; Tanja Pejovic; Paulette Mhawech-Fauceglia; Amy C Rowat; Ronny Drapkin; Beth Y Karlan; Dennis J Hazelett; Matthew L Freedman; Simon A Gayther; Houtan Noushmehr
Journal:  Cell Rep       Date:  2019-12-10       Impact factor: 9.423

6.  Identification of six new susceptibility loci for invasive epithelial ovarian cancer.

Authors:  Karoline B Kuchenbaecker; Susan J Ramus; Jonathan Tyrer; Andrew Lee; Howard C Shen; Jonathan Beesley; Kate Lawrenson; Lesley McGuffog; Sue Healey; Janet M Lee; Tassja J Spindler; Yvonne G Lin; Tanja Pejovic; Yukie Bean; Qiyuan Li; Simon Coetzee; Dennis Hazelett; Alexander Miron; Melissa Southey; Mary Beth Terry; David E Goldgar; Saundra S Buys; Ramunas Janavicius; Cecilia M Dorfling; Elizabeth J van Rensburg; Susan L Neuhausen; Yuan Chun Ding; Thomas V O Hansen; Lars Jønson; Anne-Marie Gerdes; Bent Ejlertsen; Daniel Barrowdale; Joe Dennis; Javier Benitez; Ana Osorio; Maria Jose Garcia; Ian Komenaka; Jeffrey N Weitzel; Pamela Ganschow; Paolo Peterlongo; Loris Bernard; Alessandra Viel; Bernardo Bonanni; Bernard Peissel; Siranoush Manoukian; Paolo Radice; Laura Papi; Laura Ottini; Florentia Fostira; Irene Konstantopoulou; Judy Garber; Debra Frost; Jo Perkins; Radka Platte; Steve Ellis; Andrew K Godwin; Rita Katharina Schmutzler; Alfons Meindl; Christoph Engel; Christian Sutter; Olga M Sinilnikova; Francesca Damiola; Sylvie Mazoyer; Dominique Stoppa-Lyonnet; Kathleen Claes; Kim De Leeneer; Judy Kirk; Gustavo C Rodriguez; Marion Piedmonte; David M O'Malley; Miguel de la Hoya; Trinidad Caldes; Kristiina Aittomäki; Heli Nevanlinna; J Margriet Collée; Matti A Rookus; Jan C Oosterwijk; Laima Tihomirova; Nadine Tung; Ute Hamann; Claudine Isaccs; Marc Tischkowitz; Evgeny N Imyanitov; Maria A Caligo; Ian G Campbell; Frans B L Hogervorst; Edith Olah; Orland Diez; Ignacio Blanco; Joan Brunet; Conxi Lazaro; Miquel Angel Pujana; Anna Jakubowska; Jacek Gronwald; Jan Lubinski; Grzegorz Sukiennicki; Rosa B Barkardottir; Marie Plante; Jacques Simard; Penny Soucy; Marco Montagna; Silvia Tognazzo; Manuel R Teixeira; Vernon S Pankratz; Xianshu Wang; Noralane Lindor; Csilla I Szabo; Noah Kauff; Joseph Vijai; Carol A Aghajanian; Georg Pfeiler; Andreas Berger; Christian F Singer; Muy-Kheng Tea; Catherine M Phelan; Mark H Greene; Phuong L Mai; Gad Rennert; Anna Marie Mulligan; Sandrine Tchatchou; Irene L Andrulis; Gord Glendon; Amanda Ewart Toland; Uffe Birk Jensen; Torben A Kruse; Mads Thomassen; Anders Bojesen; Jamal Zidan; Eitan Friedman; Yael Laitman; Maria Soller; Annelie Liljegren; Brita Arver; Zakaria Einbeigi; Marie Stenmark-Askmalm; Olufunmilayo I Olopade; Robert L Nussbaum; Timothy R Rebbeck; Katherine L Nathanson; Susan M Domchek; Karen H Lu; Beth Y Karlan; Christine Walsh; Jenny Lester; Alexander Hein; Arif B Ekici; Matthias W Beckmann; Peter A Fasching; Diether Lambrechts; Els Van Nieuwenhuysen; Ignace Vergote; Sandrina Lambrechts; Ed Dicks; Jennifer A Doherty; Kristine G Wicklund; Mary Anne Rossing; Anja Rudolph; Jenny Chang-Claude; Shan Wang-Gohrke; Ursula Eilber; Kirsten B Moysich; Kunle Odunsi; Lara Sucheston; Shashi Lele; Lynne R Wilkens; Marc T Goodman; Pamela J Thompson; Yurii B Shvetsov; Ingo B Runnebaum; Matthias Dürst; Peter Hillemanns; Thilo Dörk; Natalia Antonenkova; Natalia Bogdanova; Arto Leminen; Liisa M Pelttari; Ralf Butzow; Francesmary Modugno; Joseph L Kelley; Robert P Edwards; Roberta B Ness; Andreas du Bois; Florian Heitz; Ira Schwaab; Philipp Harter; Keitaro Matsuo; Satoyo Hosono; Sandra Orsulic; Allan Jensen; Susanne Kruger Kjaer; Estrid Hogdall; Hanis Nazihah Hasmad; Mat Adenan Noor Azmi; Soo-Hwang Teo; Yin-Ling Woo; Brooke L Fridley; Ellen L Goode; Julie M Cunningham; Robert A Vierkant; Fiona Bruinsma; Graham G Giles; Dong Liang; Michelle A T Hildebrandt; Xifeng Wu; Douglas A Levine; Maria Bisogna; Andrew Berchuck; Edwin S Iversen; Joellen M Schildkraut; Patrick Concannon; Rachel Palmieri Weber; Daniel W Cramer; Kathryn L Terry; Elizabeth M Poole; Shelley S Tworoger; Elisa V Bandera; Irene Orlow; Sara H Olson; Camilla Krakstad; Helga B Salvesen; Ingvild L Tangen; Line Bjorge; Anne M van Altena; Katja K H Aben; Lambertus A Kiemeney; Leon F A G Massuger; Melissa Kellar; Angela Brooks-Wilson; Linda E Kelemen; Linda S Cook; Nhu D Le; Cezary Cybulski; Hannah Yang; Jolanta Lissowska; Louise A Brinton; Nicolas Wentzensen; Claus Hogdall; Lene Lundvall; Lotte Nedergaard; Helen Baker; Honglin Song; Diana Eccles; Ian McNeish; James Paul; Karen Carty; Nadeem Siddiqui; Rosalind Glasspool; Alice S Whittemore; Joseph H Rothstein; Valerie McGuire; Weiva Sieh; Bu-Tian Ji; Wei Zheng; Xiao-Ou Shu; Yu-Tang Gao; Barry Rosen; Harvey A Risch; John R McLaughlin; Steven A Narod; Alvaro N Monteiro; Ann Chen; Hui-Yi Lin; Jenny Permuth-Wey; Thomas A Sellers; Ya-Yu Tsai; Zhihua Chen; Argyrios Ziogas; Hoda Anton-Culver; Aleksandra Gentry-Maharaj; Usha Menon; Patricia Harrington; Alice W Lee; Anna H Wu; Celeste L Pearce; Gerry Coetzee; Malcolm C Pike; Agnieszka Dansonka-Mieszkowska; Agnieszka Timorek; Iwona K Rzepecka; Jolanta Kupryjanczyk; Matt Freedman; Houtan Noushmehr; Douglas F Easton; Kenneth Offit; Fergus J Couch; Simon Gayther; Paul P Pharoah; Antonis C Antoniou; Georgia Chenevix-Trench
Journal:  Nat Genet       Date:  2015-01-12       Impact factor: 38.330

7.  Silencing LGR6 Attenuates Stemness and Chemoresistance via Inhibiting Wnt/β-Catenin Signaling in Ovarian Cancer.

Authors:  Xiaohong Ruan; Aibin Liu; Meigong Zhong; Jihong Wei; Weijian Zhang; Yingrou Rong; Wanmin Liu; Mingwei Li; Xingrong Qing; Gaowen Chen; Ronggang Li; Yuehua Liao; Qiongru Liu; Xin Zhang; Dong Ren; Yifeng Wang
Journal:  Mol Ther Oncolytics       Date:  2019-04-19       Impact factor: 7.200

8.  The Notch and Wnt pathways regulate stemness and differentiation in human fallopian tube organoids.

Authors:  Mirjana Kessler; Karen Hoffmann; Volker Brinkmann; Oliver Thieck; Susan Jackisch; Benjamin Toelle; Hilmar Berger; Hans-Joachim Mollenkopf; Mandy Mangler; Jalid Sehouli; Christina Fotopoulou; Thomas F Meyer
Journal:  Nat Commun       Date:  2015-12-08       Impact factor: 14.919

9.  Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancer.

Authors:  Lubomir Bodnar; Aleksandra Stanczak; Szczepan Cierniak; Marta Smoter; Marzena Cichowicz; Wojciech Kozlowski; Cezary Szczylik; Maciej Wieczorek; Monika Lamparska-Przybysz
Journal:  J Ovarian Res       Date:  2014-02-06       Impact factor: 4.234

Review 10.  LGR5 and LGR6 in stem cell biology and ovarian cancer.

Authors:  Adam J Schindler; Arisa Watanabe; Stephen B Howell
Journal:  Oncotarget       Date:  2017-08-11
View more
  2 in total

1.  Functional analysis of the 1p34.3 risk locus implicates GNL2 in high-grade serous ovarian cancer.

Authors:  Koji Nakamura; Brett M Reid; Ann Chen; Zhihua Chen; Ellen L Goode; Jennifer B Permuth; Jamie K Teer; Jonathan Tyrer; Xiaoqing Yu; Peter A Kanetsky; Paul D Pharoah; Simon A Gayther; Thomas A Sellers; Kate Lawrenson; Florian A Karreth
Journal:  Am J Hum Genet       Date:  2021-12-28       Impact factor: 11.043

2.  RSPO2 promotes progression of ovarian cancer through dual receptor-mediated FAK/Src signaling activation.

Authors:  Rulu Pan; Yan Yu; Haiyan Zhu; Wenyi Zhang; Yuan Qin; Lin Ye; Juji Dai; Ren Huang; Xinyan Peng; Siqi Ye; Ziqi Lin; Shishun Huang; Shuyi Chong; Liting Lu; Xincheng Lu
Journal:  iScience       Date:  2022-09-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.